Confusion Worse Confounded: A Comment on 'Withdrawl of Clinical Trials Policy by Canadian Research Institute is a 'Lost Opportunity for Increased Transparency'

Jocelyn Downie; Francoise Baylis

Confusion Worse Confounded: A Comment on 'Withdrawl of Clinical Trials Policy by Canadian Research Institute is a 'Lost Opportunity for Increased Transparency'

Dalhousie University

Research output: Contribution to journal › Article › peer-review

Abstract

According to a recent BMJ article on CIHR's decision to "disappear" its policy on clinical trial registration, "Ian Graham, CIHR's vice president Knowledge Translation and Public Outreach, stated the CIHR policy was removed 'as the overlap [with Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans (TCPS 2)] will cause confusion and inconsistent application of the requirements.'"

Ironically, this explanation is itself confusing and inconsistent with previous decisions made by CIHR. There are at least three areas in which CIHR policy/guidelines overlapped with TCPS 2 (registration and results disclosure of trials, research involving Aboriginal People, and research involving human pluripotent stem cells), and in each case CIHR took a different approach.

Original language	Canadian English
Journal	Articles, Book Chapters, & Popular Press
Publication status	Published - Jan. 1 2011

Keywords

CIHR
Response to Article
Critique
Policy and Guidelines
Clinical Trials Policy

Disciplines

Health Law and Policy
Law
Legal Writing and Research

Access to Document

Confusion Worse Confounded A Comment on Withdrawl of Clinical TFinal published version, 129 KBLicence: Unspecified

Cite this

@article{0a2de5bf86ae4663b958b8a9056e8913,

title = "Confusion Worse Confounded: A Comment on 'Withdrawl of Clinical Trials Policy by Canadian Research Institute is a 'Lost Opportunity for Increased Transparency'",

abstract = " According to a recent BMJ article on CIHR's decision to {"}disappear{"} its policy on clinical trial registration, {"}Ian Graham, CIHR's vice president Knowledge Translation and Public Outreach, stated the CIHR policy was removed 'as the overlap [with Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans (TCPS 2)] will cause confusion and inconsistent application of the requirements.'{"} Ironically, this explanation is itself confusing and inconsistent with previous decisions made by CIHR. There are at least three areas in which CIHR policy/guidelines overlapped with TCPS 2 (registration and results disclosure of trials, research involving Aboriginal People, and research involving human pluripotent stem cells), and in each case CIHR took a different approach.",

keywords = "CIHR, Response to Article, Critique, Policy and Guidelines, Clinical Trials Policy",

author = "Jocelyn Downie and Francoise Baylis",

note = "Fran{\c c}oise Baylis & Jocelyn Downie, {"}Confusion Worse Confounded: A Comment on 'Withdrawl of Clinical Trials Policy by Canadian Research Institute is a 'Lost Opportunity for Increased Transparency'{"} (4 May 2011), online: British Medical Journal < https://www.bmj.com/rapid-response/2011/11/03/confusion-worse-confounded-1 > [perma.cc/DQG3-28DS].",

year = "2011",

month = jan,

day = "1",

language = "Canadian English",

}

TY - JOUR

T1 - Confusion Worse Confounded: A Comment on 'Withdrawl of Clinical Trials Policy by Canadian Research Institute is a 'Lost Opportunity for Increased Transparency'

AU - Downie, Jocelyn

AU - Baylis, Francoise

N1 - Françoise Baylis & Jocelyn Downie, "Confusion Worse Confounded: A Comment on 'Withdrawl of Clinical Trials Policy by Canadian Research Institute is a 'Lost Opportunity for Increased Transparency'" (4 May 2011), online: British Medical Journal < https://www.bmj.com/rapid-response/2011/11/03/confusion-worse-confounded-1 > [perma.cc/DQG3-28DS].

PY - 2011/1/1

Y1 - 2011/1/1

N2 - According to a recent BMJ article on CIHR's decision to "disappear" its policy on clinical trial registration, "Ian Graham, CIHR's vice president Knowledge Translation and Public Outreach, stated the CIHR policy was removed 'as the overlap [with Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans (TCPS 2)] will cause confusion and inconsistent application of the requirements.'" Ironically, this explanation is itself confusing and inconsistent with previous decisions made by CIHR. There are at least three areas in which CIHR policy/guidelines overlapped with TCPS 2 (registration and results disclosure of trials, research involving Aboriginal People, and research involving human pluripotent stem cells), and in each case CIHR took a different approach.

AB - According to a recent BMJ article on CIHR's decision to "disappear" its policy on clinical trial registration, "Ian Graham, CIHR's vice president Knowledge Translation and Public Outreach, stated the CIHR policy was removed 'as the overlap [with Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans (TCPS 2)] will cause confusion and inconsistent application of the requirements.'" Ironically, this explanation is itself confusing and inconsistent with previous decisions made by CIHR. There are at least three areas in which CIHR policy/guidelines overlapped with TCPS 2 (registration and results disclosure of trials, research involving Aboriginal People, and research involving human pluripotent stem cells), and in each case CIHR took a different approach.

KW - CIHR

KW - Response to Article

KW - Critique

KW - Policy and Guidelines

KW - Clinical Trials Policy

UR - https://digitalcommons.schulichlaw.dal.ca/scholarly_works/938

M3 - Article

JO - Articles, Book Chapters, & Popular Press

JF - Articles, Book Chapters, & Popular Press

ER -

Confusion Worse Confounded: A Comment on 'Withdrawl of Clinical Trials Policy by Canadian Research Institute is a 'Lost Opportunity for Increased Transparency'

Abstract

Keywords

Disciplines

Access to Document

Other files and links

Fingerprint

Cite this